Cargando…

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies

Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders characterized by progressive muscle wasting and weakness likely associated with exhaustion of muscle regeneration potential. At present, no cures or efficacious treatments are available for these diseases, but cell transplan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salani, Sabrina, Donadoni, Chiara, Rizzo, Federica, Bresolin, Nereo, Comi, Giacomo P, Corti, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823206/ https://www.ncbi.nlm.nih.gov/pubmed/22129481 http://dx.doi.org/10.1111/j.1582-4934.2011.01498.x

Ejemplares similares

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
por: Piga, Daniela, et al.
Publicado: (2019)

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014)

Direct reprogramming of human astrocytes into neural stem cells and neurons
por: Corti, Stefania, et al.
Publicado: (2012)

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015)

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
por: Nizzardo, Monica, et al.
Publicado: (2015)

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
por: Nizzardo, Monica, et al.
Publicado: (2014)

Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014)

MicroRNAs as serum biomarkers in Becker muscular dystrophy
por: Gagliardi, Delia, et al.
Publicado: (2022)

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
por: Rizzo, Federica, et al.
Publicado: (2019)

MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis
por: Gagliardi, Delia, et al.
Publicado: (2019)

Neurocognitive Profiles in Duchenne Muscular Dystrophy and Gene Mutation Site
por: D’Angelo, Maria Grazia, et al.
Publicado: (2011)

Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019)

ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases
por: Magri, Francesca, et al.
Publicado: (2015)

Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
por: Ramirez, Agnese, et al.
Publicado: (2018)

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
por: Rizzo, Federica, et al.
Publicado: (2017)

Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
por: Abati, Elena, et al.
Publicado: (2021)

Neural Stem Cell Transplantation for Neurodegenerative Diseases
por: De Gioia, Roberta, et al.
Publicado: (2020)

Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
por: Gagliardi, Delia, et al.
Publicado: (2020)

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
por: Lerario, Alberto, et al.
Publicado: (2010)

Mitochondrial Fusion Proteins and Human Diseases
por: Ranieri, Michela, et al.
Publicado: (2013)

Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients
por: Magri, Francesca, et al.
Publicado: (2012)

Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene
por: Magri, Francesca, et al.
Publicado: (2022)

Animal Models of CMT2A: State-of-art and Therapeutic Implications
por: De Gioia, Roberta, et al.
Publicado: (2020)

Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
por: Costamagna, Gianluca, et al.
Publicado: (2020)

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
por: Manini, Arianna, et al.
Publicado: (2022)

Limb girdle muscular dystrophy due to LAMA2 gene mutations: new mutations expand the clinical spectrum of a still challenging diagnosis
por: Magri, Francesca, et al.
Publicado: (2020)

Growing Evidence about the Relationship between Vessel Dissection and Scuba Diving
por: Brajkovic, Simona, et al.
Publicado: (2013)

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
por: Gagliardi, Delia, et al.
Publicado: (2019)

Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model
por: Torrente, Yvan, et al.
Publicado: (2003)

Dystonia‐ataxia syndrome with permanent torsional nystagmus caused by ECHS1 deficiency
por: Ronchi, Dario, et al.
Publicado: (2020)

Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
por: Kalra, Spandan, et al.
Publicado: (2016)

Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies
por: Bruge, Celine, et al.
Publicado: (2022)

A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformations
por: Lanfranconi, Silvia, et al.
Publicado: (2014)

Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
por: Bersani, Margherita, et al.
Publicado: (2022)

Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures
por: Lerario, Alberto, et al.
Publicado: (2012)

Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
por: Danisovic, Lubos, et al.
Publicado: (2018)

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
por: Rizzo, Federica, et al.
Publicado: (2023)

A Novel Homozygous VPS11 Variant May Cause Generalized Dystonia
por: Monfrini, Edoardo, et al.
Publicado: (2021)

Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients
por: Marchesi, Chiara, et al.
Publicado: (2008)

Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice
por: Pagliarani, Serena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iok8iqg61500sdo9mbbap9v72p